EP102 Safety and Efficacy in METTL3 Modulation in Advanced Solid Tumors
EP102 Safety and Efficacy in METTL3 Modulation in Advanced Solid Tumors
Recruiting · NCT07163325 · Registry updated 2026-06-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| EP102 Safety and Efficacy in METTL3 Modulation in Advanced Solid Tumors | Advanced Solid Tumor (Phase 1) | Recruiting | Phase 1 | 2026-06-11 | NCT07163325 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Epics Therapeutics | 1 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cliniques Universitaires Saint-Luc | Brussels | Belgium | 147 |
| Hospital Universitari Vall d'Hebron - Vall d'Hebron Institute of Oncology | Barcelona | Spain | 1 |
| Hospital Universitario de Santiago de Compostela | Santiago de Compostela | Spain | 1 |
| Institut Jules Bordet | Brussels | Belgium | 29 |
| Leuven Cancer Institute (LKI) | Leuven | Belgium | 1 |
| Masaryk Memorial Cancer Institute | Brno | Czechia | 4 |
| Netherlands Cancer Institute (NKI) | Amsterdam | Netherlands | 1 |
| Olomouc University Hospital | Olomouc | Czechia | 1 |
| START Madrid - CIOCC | Madrid | Spain | 2 |
| Universitair Ziekenhuis Gent (UZ Gent) - Drug Research Unit Gent (DRUG) | Ghent | Belgium | 1 |
| University Medical Center Groningen, University of Groningen Department of Medical Oncology | Groningen | Netherlands | 1 |